BioMarin to Participate in Four Upcoming Virtual Investor Conferences - Oct 25, 2021

• Jefferies Gene Therapy/Editing Summit on October 28 at 2:30pm ET
• Credit Suisse 30th Annual Healthcare Conference on November 10 at 1:50pm ET
• Barclays Gene Editing & Gene Therapy Summit on November 15 at 4:00pm ET
• Stifel 2021 Virtual Healthcare Conference on November 17 at 11:20am ET

SAN RAFAEL, Calif., Oct. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-four-upcoming-virtual-investor-conferences-301407128.html

SOURCE BioMarin Pharmaceutical Inc.

Company Codes: NASDAQ-NMS:BMRN